-
Botulinum Toxin Type-A — Korean Brand Clinical Survey 2026
A journal-of-medicine reading of the Korean botulinum toxin type-A landscape in 2026 — what MFDS clearance distinguishes between Hutox, Nabota, Coretox, Meditoxin, Wonder-Tox, and Liztox, and how the
-
Juvelook (PDLLA) + MFU Combination — A Korean Clinical Reading
A journal-of-medicine reading of the Juvelook PDLLA microsphere booster stacked with microfocused ultrasound lifting in Korea in 2026 — what the published literature actually shows about the layered p
-
Hydrodermabrasion / Aqua Peel — Device Categorization and Clinical Reading
Hydrodermabrasion, often marketed in Korea as aqua peel, hydro peel, or hydrafacial, is a category of vacuum-assisted serum-infusion devices that exfoliate the stratum corneum while delivering aqueous
-
Non-Surgical Nose Augmentation in Korea — A 2026 Clinical Reading
A clinical-literature reading of non-surgical nose augmentation as practised in Korean clinics in 2026 — what the dorsum, tip, and columellar protocols actually do, what the vascular-safety record loo
-
Rejuran vs Plinest — Polynucleotide Clinical Comparison 2026
A journal-of-medicine reading of the two anchor polynucleotide skin boosters available in Korea in 2026 — Rejuran from Pharma Research and Plinest from Mastelli — with attention to molecular source, p
-
Exosome vs PDRN vs Skin Booster — A Korean Clinical Comparison
A journal-of-medicine reading of the regenerative trio in Korea in 2026 — what the published literature actually shows about exosome paracrine signalling, PDRN tissue repair, and the broader skin-boos
-
PDLLA Microsphere Clinical Evidence — A 2026 Korean Survey
A journal-of-medicine reading of PDLLA microsphere biostimulators in Korea in 2026 — what the published literature actually shows, what the MFDS clearance record covers, and how senior Seoul houses se
-
Stem Cell Aesthetic Medicine in Korea — Regulatory Class & Clinical Reading
A journal-of-medicine reading of the Korean stem cell aesthetic regulatory framework — the MFDS class assignment, the MOHW Advanced Regenerative Medicine Center designation pathway, the autologous-ver